Evidence map›Paper›PMID 37253037›Full record

ArticlePLoS neglected tropical diseases2023

An economic evaluation of Wolbachia deployments for dengue control in Vietnam.

Hugo C Turner, Duong Le Quyen, Reynold Dias, Phan Thi Huong, Cameron P Simmons, Katherine L Anders

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Long-Term Durability and Public Health Impact of City-WideTropical medicine and infectious disease · 2025
    Article
  10. Review
  11. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Cost-effectiveness of aLancet regional health. Americas · 2024
    Article
  15. Article
  16. An overview of the perspectives used in health economic evaluations.Cost effectiveness and resource allocation : C/E · 2024
    Review
  17. Updates on traditional methods for combating malaria and emergingFrontiers in cellular and infection microbiology · 2024
    Review
  18. Observational
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hugo C TurnerMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0002-8428-3874
Duong Le QuyenWorld Mosquito Program, Ho Chi Minh City, Vietnam.
Reynold DiasWorld Mosquito Program, Monash University, Clayton, Australia.
Phan Thi HuongDepartment of Preventive Medicine, Ministry of Health, Hanoi, Vietnam.
Cameron P SimmonsWorld Mosquito Program, Monash University, Clayton, Australia.
Katherine L AndersWorld Mosquito Program, Monash University, Clayton, Australia.

Funding

Medical Research Council MR/R015600/1Wellcome Trust
6 · The paper itself

Abstract

introductionDengue is a major public health challenge and a growing problem due to climate change. The release of Aedes aegypti mosquitoes infected with the intracellular bacterium Wolbachia is a novel form of vector control against dengue. However, there remains a need to evaluate the benefits of such an intervention at a large scale. In this paper, we evaluate the potential economic impact and cost-effectiveness of scaled Wolbachia deployments as a form of dengue control in Vietnam-targeted at the highest burden urban areas.

methodsTen settings within Vietnam were identified as priority locations for potential future Wolbachia deployments (using a population replacement strategy). The effectiveness of Wolbachia deployments in reducing the incidence of symptomatic dengue cases was assumed to be 75%. We assumed that the intervention would maintain this effectiveness for at least 20 years (but tested this assumption in the sensitivity analysis). A cost-utility analysis and cost-benefit analysis were conducted.

resultsFrom the health sector perspective, the Wolbachia intervention was projected to cost US$420 per disability-adjusted life year (DALY) averted. From the societal perspective, the overall cost-effectiveness ratio was negative, i.e. the economic benefits outweighed the costs. These results are contingent on the long-term effectiveness of Wolbachia releases being sustained for 20 years. However, the intervention was still classed as cost-effective across the majority of the settings when assuming only 10 years of benefits.

conclusionOverall, we found that targeting high burden cities with Wolbachia deployments would be a cost-effective intervention in Vietnam and generate notable broader benefits besides health gains.

Indexed as

AedesDengueWolbachiaAnimalsCost-Benefit AnalysisHumansMosquito VectorsVietnam

Identifiers

PMID37253037
PMCPMC10256143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.